Open-Label, Phase 3B/4 Study Of Trastuzumab Deruxtecan (T-Dxd) In Patients With Or Without Baseline Brain Metastasis With Advanced/Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Destiny-Breast12
Trastuzumab Deruxtecan
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Open-Label, Phase 3B/4 Study Of Trastuzumab Deruxtecan (T-Dxd) In Patients With Or Without Baseline Brain Metastasis With Advanced/Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Destiny-Breast12 ### Output: Trastuzumab Deruxtecan